Following its emergence from Chapter 11 bankruptcy protection, KaloBios is in the process of reacquiring company shares owned by its disgraced former CEO.

NephroGenex disclosed in a U.S. SEC filing that it had terminated Pierre Legault as CEO and president as well as Jaikrishna Patel, the company’s chief scientific officer.

STOCKHOLM–(BUSINESS WIRE)–Aerocrine (STO:AEROB) As previously announced, today is the last day of trading in the Aerocrine stock on Nasdaq Stockholm. Following completion of the recent public tender offer, Circassia Pharmaceuticals Plc (“Circassia”) has initiated a mandatory redemption procedure to acquire all shares not already held by Circassia. Further information on the redemption procedure will be […]